Non-pharmacological control of atherosclerosis
Non-pharmacological control of atherosclerosis
批准号:
7986579
负责人:
Sampath Parthasarathy
金额:
$38.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-05-31
关键词:
AffectAgonistAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntiatherogenicAntihypertensive AgentsAntioxidantsAtherosclerosisBile AcidsBiologicalCell Culture TechniquesCellsChemicalsChildCholesterolComplementDevelopmentDietDietary OilsDiseaseDrug Delivery SystemsElementsFailureFatty AcidsFatty acid glycerol estersGene ExpressionGene TargetingGenesGoalsHealth Care CostsHumanIn VitroInflammationInflammatoryLDL-R knockout mouseLeadLipidsLiteratureLow Density Lipoprotein ReceptorMediatingMolecularMono-SMusNatureOilsOlive oil preparationPharmaceutical PreparationsPharmacologic SubstancePlasmaPlayPolyunsaturated Fatty AcidsPreventionPrevention strategyProcessPropertyPulmonary HypertensionRoleRuptureSamplingSesame OilSunflower OilSupplementationTestingTherapeuticThrombosisTranscriptional ActivationUnsaturated FatsUnsaturated Fatty AcidsVitaminsbaseblood lipidcardiovascular risk factorcomparative efficacycytokinedosagedrug developmentfeedinghigh riskhuman subjectknockout animalnovelplaque lesionpreventpublic health relevanceresearch studyreverse cholesterol transportsesamoltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Inflammatory nature of atherosclerosis and the vulnerability of the plaque have suggested the need to identify agents that would inhibit these processes in the treatment of the disease. We recently observed that the administration of sesame oil to atherosclerotic mice not only reduced the blood lipids by 50% but also prevented atherosclerosis by over 85%. Preliminary results indicated that sesame oil inhibited the expression of pro-inflammatory genes and genes related to plaque vulnerability while it enhanced the expression of genes involved in reverse cholesterol transport. There are two potential possibilities-.-these effects are due hitherto unknown effects of the fatty acid constituents of sesame oil (It contains almost equal amounts of mono and polyunsaturated fatty acids), or due to its unusual non-saponifiable components. The results also posed an important question, whether lowering of plasma lipids themselves resulted in the decrease of inflammation and promoted plaque stability and increased reverse cholesterol transport or the gene effects of sesame oil or its constituents were responsible for the observed decrease in lipids and atherosclerosis. Sesame oil contains equal amounts of mono- and poly unsaturated fatty acids and contains bio-active non-saponifiable components that are potent antioxidants and PPAR1 agonists. The overall goal of the study is to determine the mechanisms by which fatty acid components and non- saponifiable components of sesame oil could exert beneficial in atherosclerosis. In lieu of vitamin E's failure in protecting human atherosclerosis, identification of the mechanisms by which the non-saponifiable components of sesame oil might complement the anti-atherosclerotic effects of dietary unsaturated fat could lead to major new pharmacological alternatives and directions. The Goals of the proposed studies are: 1. To compare the efficacy of sesame oil with sunflower oil in its anti-atherosclerotic effects with using LDL receptor knockout animals and to delineate and identify the anti-atherosclerotic effects of its non- saponifiable components. 2. Identify the anti-atherosclerotic genes that are regulated by sesame oil and its saponifiable and non- saponifiable components and to define potential molecular mechanisms that may be involved in their action. 3. To determine whether sesame oil supplementation decrease markers of cardiovascular risk in normal and high risk human subjects. Implications: Dietary prevention of atherosclerosis has major advantages to pharmacological control, being inexpensive, sensible, and healthy. The proposed study could lead to the identification of components that could be "cheap" alternatives to expensive medication offering valuable "adjunct therapy" to existing medications, It would also lead to new class of drug development.
PUBLIC HEALTH RELEVANCE: We recently identified that feeding sesame oil inhibited atherosclerosis. Analysis of genes affected by feeding sesame oil indicated that components of sesame oil inhibited several facets of atherosclerosis, including blood lipids, genes involved in cholesterol transport, inflammation, and the stability of the plaque. In the proposed study we plan to determine whether sesame oil possesses additional components with anti-atherosclerotic properties distinct from what could be ascribed to its fatty acid constituents. Dietary prevention of atherosclerosis has major advantages to pharmacological control, being inexpensive, sensible, and healthy. The proposed study could lead to the identification of components that could be "cheap" alternatives to expensive medication and also by offering valuable "adjunct therapy" to existing medications,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of aldehyde oxidation in atherosclerosis
-
批准号:8824965
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2014
-
负责人:Sampath Parthasarathy
-
依托单位:
Role of aldehyde oxidation in atherosclerosis
-
批准号:8721678
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2014
-
负责人:Sampath Parthasarathy
-
依托单位:
BMP-7 induced Macrophage Polarization in Atherosclerosis
-
批准号:8896859
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2013
-
负责人:Sampath Parthasarathy
-
依托单位:
BMP-7 induced Macrophage Polarization in Atherosclerosis
-
批准号:8723277
-
项目类别:
-
资助金额:$35.61万
-
财政年份:2013
-
负责人:Sampath Parthasarathy
-
依托单位:
BMP-7 induced Macrophage Polarization in Atherosclerosis
-
批准号:8599047
-
项目类别:
-
资助金额:$34.36万
-
财政年份:2013
-
负责人:Sampath Parthasarathy
-
依托单位:
Non-pharmacological control of atherosclerosis
-
批准号:8400472
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2010
-
负责人:Sampath Parthasarathy
-
依托单位:
Non-pharmacological control of atherosclerosis
-
批准号:8665394
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2010
-
负责人:Sampath Parthasarathy
-
依托单位:
Non-pharmacological control of atherosclerosis
-
批准号:8286089
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2010
-
负责人:Sampath Parthasarathy
-
依托单位:
Non-pharmacological control of atherosclerosis
-
批准号:8530158
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2010
-
负责人:Sampath Parthasarathy
-
依托单位:
Non-pharmacological control of atherosclerosis
-
批准号:8090508
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2010
-
负责人:Sampath Parthasarathy
-
依托单位:
Novel mechanisms by which aspirin might protect against atherosclerosis
-
批准号:7636853
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2008
-
负责人:Sampath Parthasarathy
-
依托单位:
Novel mechanisms by which aspirin might protect against atherosclerosis
-
批准号:8399146
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2008
-
负责人:Sampath Parthasarathy
-
依托单位:
Novel mechanisms by which aspirin might protect against atherosclerosis
-
批准号:7524749
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2008
-
负责人:Sampath Parthasarathy
-
依托单位:
Novel mechanisms by which aspirin might protect against atherosclerosis
-
批准号:8298595
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2008
-
负责人:Sampath Parthasarathy
-
依托单位:
Novel mechanisms by which aspirin might protect against atherosclerosis
-
批准号:7842665
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2008
-
负责人:Sampath Parthasarathy
-
依托单位:
CLINICAL TRIAL: SESAME OIL CONSUMPTION ON CARDIOVASCULAR RISK FACTORS IN HEALTHY
-
批准号:7718671
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2007
-
负责人:Sampath Parthasarathy
-
依托单位:
ACTIVE ROLE FOR THE PERITONEAL FLUID IN THE DEVELOPMENT OF ENDOMETRIOSIS
-
批准号:6564752
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:Sampath Parthasarathy
-
依托单位:
MACROPHAGE ENDOMETRIAL CELL INTERACTIONS IN ENDOMETRIOSIS
-
批准号:6564751
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:Sampath Parthasarathy
-
依托单位:
Oxidation Hypothesis--Paradoxes and Pitfalls
-
批准号:6983415
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2001
-
负责人:Sampath Parthasarathy
-
依托单位:
Oxidation Hypothesis--Paradoxes and Pitfalls
-
批准号:7231915
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2001
-
负责人:Sampath Parthasarathy
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: